Skip to main content
SpringerLink
Log in

Atazanavir/dapsone

Hyperbilirubinaemia due to dapsone-induced haemolysis and atazanavir therapy: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. East J, Blanton LS.Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy. Antimicrobial Agents and Chemotherapy 56: 1081-1083, No. 2, Feb 2012. Available from: URL: http://dx.doi.org/10.1128/aac.05806-11 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atazanavir/dapsone. React. Wkly. 1394, 9 (2012). https://doi.org/10.2165/00128415-201213940-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00028

Keywords

Search

Navigation